INHIBITION OF PROLIFERATION OF LINES DERIVED FROM HUMAN CERVICAL CARCINOMAS BY CYTO-TOXIC DRUGS AND BY RECOMBINANT INTERFERONS

被引：10
作者：
JACOBS, AJ [1 ]
DAWOUD, L [1 ]
KOVACS, Z [1 ]
RATLIFF, TL [1 ]
机构：
[1] WASHINGTON UNIV,MED CTR,JEWISH HOSP,DEPT SURG,DIV UROL,ST LOUIS,MO 63110
来源：
GYNECOLOGIC ONCOLOGY | 1989年 / 32卷 / 01期
关键词：
D O I：
10.1016/0090-8258(89)90845-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：31 / 36
页数：6
相关论文
共 42 条
[1]  
BEREK JS, 1985, CANCER RES, V45, P4447
[2]   RANDOMIZED TRIAL OF 3 CISPLATIN DOSE SCHEDULES IN SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
BONOMI, P ;
BLESSING, JA ;
STEHMAN, FB ;
DISAIA, PJ ;
WALTON, L ;
MAJOR, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (08) :1079-1085
[3]   A NEW TYPE OF PAPILLOMAVIRUS DNA, ITS PRESENCE IN GENITAL CANCER BIOPSIES AND IN CELL-LINES DERIVED FROM CERVICAL-CANCER [J].
BOSHART, M ;
GISSMANN, L ;
IKENBERG, H ;
KLEINHEINZ, A ;
SCHEURLEN, W ;
HAUSEN, HZ .
EMBO JOURNAL, 1984, 3 (05) :1151-1157
[4]   INTERFERON AND CELL-DIVISION .8. EFFECT OF INTERFERON ON MACROMOLECULAR SYNTHESIS IN L1210 CELLS IN-VITRO [J].
BROUTYBOYE, D ;
MACIEIRA.A ;
FISZMAN, M ;
GRESSER, I .
INTERNATIONAL JOURNAL OF CANCER, 1973, 12 (01) :250-258
[5]   CERVIX CARCINOMA - TREATMENT WITH COMBINATION CISPLATIN AND BLEOMYCIN [J].
DAGHESTANI, AN ;
HAKES, TB ;
LYNCH, G ;
LEWIS, JL .
GYNECOLOGIC ONCOLOGY, 1983, 16 (03) :334-339
[6]   SYNERGISM IN THE ANTI-TUMOR EFFECTS OF TYPE-1 AND TYPE-II INTERFERON IN MICE INOCULATED WITH LEUKEMIA-L1210 CELLS [J].
DECLERCQ, E ;
ZHANG, ZX ;
HUYGEN, K .
CANCER LETTERS, 1982, 15 (03) :223-228
[7]  
DIPALO G, 1985, J REPROD MED, V30, P404
[8]   A PAPILLOMAVIRUS DNA FROM A CERVICAL-CARCINOMA AND ITS PREVALENCE IN CANCER BIOPSY SAMPLES FROM DIFFERENT GEOGRAPHIC REGIONS [J].
DURST, M ;
GISSMANN, L ;
IKENBERG, H ;
ZURHAUSEN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12) :3812-3815
[9]  
ELION GB, 1954, J BIOL CHEM, V208, P477
[10]  
EPSTEIN LB, 1981, CANCER CHEMOTH PHARM, V6, P273
12345